FDA.report

Application 072695

Type
ANDA
Sponsor
BARR

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001NORTREL 0.5/35-28ETHINYL ESTRADIOL; NORETHINDRONETABLET;ORAL-280.035MG;0.5MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
0555-9008NortrelNorethindrone and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9008NortrelNorethindrone and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9008NortrelNorethindrone and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9008NortrelNorethindrone and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9008NortrelNorethindrone and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-9008NortrelNorethindrone and Ethinyl EstradiolTeva Pharmaceuticals USA, Inc.ANDACurrent
50090-3229NortrelNorethindrone and Ethinyl EstradiolA-S Medication SolutionsANDACurrent
51862-318NeconNorethindrone and Ethinyl EstradiolMayne Pharma Inc.ANDACurrent
51862-318NeconNorethindrone and Ethinyl EstradiolMayne Pharma Inc.ANDACurrent
51862-318NeconNorethindrone and Ethinyl EstradiolMayne Pharma Inc.ANDACurrent